Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future ; volume:2 ; number:1 ; day:1 ; month:3 ; year:2023 ; pages:1-6 ; date:12.2023
Holistic integrative oncology ; 2, Heft 1 (1.3.2023), 1-6, 12.2023
- Urheber
-
Wang, Zi-Xian
Xu, Rui-Hua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44178-023-00028-x
- URN
-
urn:nbn:de:101:1-2023120221455377434236
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Zi-Xian
- Xu, Rui-Hua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Immunotherapy for Esophageal Squamous Cell Carcinoma
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Immunotherapy for Esophageal Squamous Cell Carcinoma
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Immunotherapy for Esophageal Squamous Cell Carcinoma
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy